Works by Ludkovski, O.


Results: 7
    1

    In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading.

    Published in:
    2016
    By:
    • Picanço-Albuquerque, C.;
    • Morais, C.;
    • Carvalho, F.;
    • Peskoe, S.;
    • Hicks, J.;
    • Ludkovski, O.;
    • Vidotto, T.;
    • Fedor, H.;
    • Humphreys, E.;
    • Han, M.;
    • Platz, E.;
    • Marzo, A.;
    • Berman, D.;
    • Lotan, T.;
    • Squire, J.;
    • Picanço-Albuquerque, C G;
    • Morais, C L;
    • Carvalho, F L F;
    • Peskoe, S B;
    • Hicks, J L
    Publication type:
    journal article
    2
    3
    4

    Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer: National Cancer Institute of Canada Clinical Trials Group Study PA.3.

    Published in:
    2010
    By:
    • da Cunha Santos G;
    • Dhani N;
    • Tu D;
    • Chin K;
    • Ludkovski O;
    • Kamel-Reid S;
    • Squire J;
    • Parulekar W;
    • Moore MJ;
    • Tsao MS;
    • da Cunha Santos, Gilda;
    • Dhani, Neesha;
    • Tu, Dongsheng;
    • Chin, Kayu;
    • Ludkovski, Olga;
    • Kamel-Reid, Suzanne;
    • Squire, Jeremy;
    • Parulekar, Wendy;
    • Moore, Malcolm J;
    • Tsao, Ming Sound
    Publication type:
    journal article
    5
    6
    7